

Fundamental dimension Equity attribute | DRCTLeader $0.910.00% Cap $692.1KP/E -0.0x QuantScore35/100 | BAOSPeer $0.1663▼-2.06% Cap $255.2KP/E -0.0x QuantScore27/100 | BBGIPeer $7.62▼-4.39% Cap $15.64MP/E -0.1x QuantScore26/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
23/100 |
45/100 |
53/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 0/100 | 33/100 |
Health Piotroski, Altman Z, leverage & liquidity | 27/100 | 40/100 | 12/100 |
Growth Revenue / earnings growth & margins | 0/100 | 25/100 | 5/100 |
Sentiment Analyst ratings, targets & revisions | 92/100 | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.0x | -0.0x | -0.1x |
Forward P/E (next FY) | -0.0x | — | 0.2x |
EV / EBITDA (TTM) | -0.8x | -0.0x | -0.9x |
Price / Sales | 0.0x | 0.7x | 0.1x |
Price / Free Cash Flow | -0.1x | -0.1x | -0.6x |
PEG ratio | 0.00 | -0.00 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 2 / 9 | 4 / 9 |
Altman Z-Score | -7.21 (Distress) | -7.12 (Distress) | -2.25 (Distress) |
Total debt / equity | -2.15 | 0.11 | 4.55 |
Quick ratio | 0.1x | 2.6x | 1.2x |
Interest coverage | -8.2x | -247.8x | -0.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -44.3% | -8.8% | -14.3% |
Net income growth YoY | -203.8% | +55.3% | -3238.6% |
Gross margin (TTM) | 19.0% | -136.0% | 31.8% |
Operating margin (FY) | -42.5% | -1310.3% | -2.4% |
FCF margin (FY) | -25.9% | -397.8% | -6.5% |
5. Trailing price performancePrice change over period |
1M return | -42.4% | -40.2% | -52.5% |
3M return | -64.3% | -85.8% | -62.9% |
6M return | -62.6% | -93.9% | -65.0% |
Year to date | -93.6% | -93.9% | +52.1% |
1Y return | -98.8% | -94.8% | +36.1% |
3Y return | -99.8% | -96.4% | -46.0% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-83.75 -9303.6% premium | $-1.15 -791.4% premium | $-727.43 -9646.3% premium |
Wall Street consensus target | $440.00 +48251.6% · range $440.00–$440.00 | — — | — — |
Consensus stance | 80% Buy20% Hold0% Sell | — | — |